Face Mask Not Required For People Of Color

People of color are exempt from Oregon county’s mandatory mask order

Subscribe to the The Dollar Vigilante newsletter: https://www.dollarvigilante.com/subsc…
Oregon county has decided to make people of color exempt from its mandatory mask policy, citing the potential for racial profiling.The decision comes as multiple counties in Oregon have ramped up face-covering requirements to slow the spread of coronavirus. Lincoln County’s general directive requires everyone to wear a face-covering in any indoor public setting, or any outdoor setting where six feet of social distancing can’t be maintained.But the county wrote on its website that “People of color who have heightened concerns about racial profiling and harassment due to wearing face coverings in public” are exempt from the rule.According to census data, Lincoln County is more than 80% white. Face coverings will be required when visiting businesses in seven Oregon counties starting Wednesday. There are more than 7,400 virus cases in the state, and 195 deaths as of Wednesday, according to the state’s department of health.

Face Mask Not Required For People Of Color

Other exemptions include children under the age of 12 and people with particular medical conditions or disabilities.  By Victoria Albert CBS News Full Story


THE SCIENCE IS SETTLED…..wearing a #COVID19  mask starves your brain of oxygen!

New Meta-Analysis Raises Doubts That Masks Work To Prevent COVID Infection and Transmission

A newly released meta-analysis on the use of face masks for reducing the transmission of viral respiratory infections within community settings shows the evidence for their effectiveness is equivocal at best. 

Titled, “Face masks to prevent community transmission of viral respiratory infections: A rapid evidence review using Bayesian analysis,” the study analyzed eleven randomized, controlled trials and 10 observational studies, concluding:

“Available evidence from RCTs is equivocal as to whether or not wearing face masks in community settings results in a reduction in clinically- or laboratory-confirmed viral respiratory infections. No relevant studies concerned SARS-CoV-2 or were undertaken in community settings in the UK.”

Here is an example they provided of the highly equivocal nature of their study findings:

“One study found lower rates of self-reported symptoms of influenza-like illness (ILI) in the intervention compared with the control arm; however, in secondary analyses with laboratory-confirmed ILI, the rate of infection was less in the control arm than the intervention arm.”

The researchers pointed out that there is considerable controversy on the topic of the effectiveness of mask wearing, and proper risk/benefit analyses should be conducted given their implications to health policy.

They noted that while face masks filter droplets believed to contain viruses like SARS-CoV-2, they also have a number of drawbacks. For instance, if not used correctly, they:

“…may even increase transmission if they act as fomites [objects or materials which are likely to carry infection] or prompt other behaviours that transmit the virus such as face touching. For example, a face mask that has been worn for several hours becomes moist and acts as a potential source of contamination. Studies show that people touch their faces 15-23 times per hour on average (9,10), and this may mean that eyes and contaminated face masks are touched, spreading the virus.”

The researchers commented on the implications of their findings for policy and practice:

“While the potentially biased self-reported outcomes from RCTs suggest a small benefit of face mask wearing, findings on clinically- and laboratory-confirmed infection remain equivocal. In addition, none of the studies concerned SARS-CoV-2 and none were conducted in the UK. All were in community settings that were different in many respects from the situation pertaining to SARS-CoV-2 in the UK. In light of this, judgements about the benefits or harms of wearing face masks will have to be made using a priori arguments rather than the data reviewed here: the scientific evidence should be considered equivocal. Such arguments should pay special attention to specific settings where the risk of infection is high and the opportunity for physical distancing is low (e.g. on crowded public transport), and to the need for education and training to maximise the potential benefits of wearing masks and mitigate the risk that they will transmit infection by acting as fomites.”

This study was the subject of a recent article titled, “Four potential consequences of wearing face masks we need to be wary of” published on www.theconversation.com, and which is well worth reading.

Clearly, in a time and age when mandatory medical interventions, including so-called non-pharmaceutical interventions such as social distancing, hand-washing, and mask wearing, are increasingly being implemented and institutionalized under the auspices of the public safety, we need to let the evidence itself (and not simply fear and a desire to control) guide these public health decisions and policies. When the evidence of safety and effectiveness is lacking, or worse, when there is evidence of unsafety and ineffectiveness, it is our job to inform ourselves and others, and not consent to unethical, unlawful, or unconstitutional orders that violate our health and bodily sovereignty. Join the non-profit, health freedom advocacy project www.Standforhealthfreedom.com to learn more about your rights and what you can do to protect them.

Cannabis May Stop Coronavirus From Infecting People, Study Finds.

While smoking weed may not make you coronavirus-proof, Canadian scientists at the University of Lethbridge have some promising results that might be counted as preliminary evidence that cannabis may block COVID-19 infection.

A new study from Canada suggests that cannabis extracts containing THC and CBD could prevent the novel coronavirus from infecting human cells.

The study, published online at Preprints, was conducted by a team of biologists licensed to grow marijuana and hemp under a Health Canada research license. Using 13 different cannabis oils extracted from newly developed strains, the team discovered that certain oils containing the cannabinoids CBD and THC could lower human cell production of two key proteins that serve as gateways for COVID-19 virus to enter the body and cause infection.

Scientists believe that the novel coronavirus primarily spreads when infected individuals talk or breathe within six feet of other people. The moisture droplets that exit the infected person’s mouth travel by air and are inhaled or swallowed by other people in proximity. As the virus travels into a new host’s throat or sinuses (and possibly even the digestive system), it stabs its “corona” spikes into a cellular protein found throughout the body called ACE2.

However, it should be stressed that the researchers are not saying that weed is a cure for the coronavirus. Rather, cannabis extracts could work as an “adjunct therapy” in new medical products that could reduce the chances of someone getting COVID-19.

In Search of Preventative Strategies: Novel Anti-Inflammatory High-CBD Cannabis Sativa Extracts Modulate ACE2 Expression in COVID-19 Gateway Tissues

With the rapidly growing pandemic of COVID-19 caused by the new and challenging to treat zoonotic SARS-CoV2 coronavirus, there is an urgent need for new therapies and prevention strategies that can help curtail disease spread and reduce mortality. Inhibition of viral entry and thereby spread constitute plausible therapeutic avenues.

Similar to other respiratory pathogens, SARS-CoV2 is transmitted through respiratory droplets, with potential for aerosol and contact spread. It uses receptor-mediated entry into the human host via angiotensin-converting enzyme II (ACE2) that is expressed in lung tissue, as well as oral and nasal mucosa, kidney, testes, and the gastrointestinal tract.

Modulation of ACE2 levels in these gateway tissues may prove a plausible strategy for decreasing disease susceptibility. Cannabis sativa, especially one high in the anti-inflammatory cannabinoid cannabidiol (CBD), has been proposed to modulate gene expression and inflammation and harbour anti-cancer and anti-inflammatory properties.

Working under the Health Canada research license, we have developed over 800 new Cannabis sativa lines and extracts and hypothesized that high-CBD C. sativa extracts may be used to modulate ACE2 expression in COVID-19 target tissues. Screening C. sativa extracts using artificial human 3D models of oral, airway, and intestinal tissues, we identified 13 high CBD C. sativa extracts that modulate ACE2 gene expression and ACE2 protein levels.

Our initial data suggest that some C. sativa extract down-regulate serine protease TMPRSS2, another critical protein required for SARS-CoV2 entry into host cells. While our most effective extracts require further large-scale validation, our study is crucial for the future analysis of the effects of medical cannabis on COVID-19.

The extracts of our most successful and novel high CBD C. sativa lines, pending further investigation, may become a useful and safe addition to the treatment of COVID-19 as an adjunct therapy. They can be used to develop easy-to-use preventative treatments in the form of mouthwash and throat gargle products for both clinical and at-home use.

Such products ought to be tested for their potential to decrease viral entry via the oral mucosa. Given the current dire and rapidly evolving epidemiological situation, every possible therapeutic opportunity and avenue must be considered.

Study Shows Cannabis May Block COVID-19 Infection

https://www.preprints.org/manuscript/202004.0315/v1

https://merryjane.com/news/cannabis-may-stop-coronavirus-from-infecting-people-study-finds

Blaylock: Face Masks Pose Serious Risks To The Healthy

Dr. Russell Blaylock warns that not only do face masks fail to protect the healthy from getting sick, but they also create serious health risks to the wearer. The bottom line is that if you are not sick, you should not wear a face mask.As businesses reopen, many are requiring shoppers and employees to wear a face mask. Costco, for instance, will not allow shoppers into the store without wearing a face mask. Many employers are requiring all employees to wear a face mask while at work. In some jurisdictions, all citizens must wear a face mask if they are outside of their own home.  ⁃ TN Editor

With the advent of the so-called COVID-19 pandemic, we have seen a number of medical practices that have little or no scientific support as regards reducing the spread of this infection. One of these measures is the wearing of facial masks, either a surgical-type mask, bandana or N95 respirator mask. When this pandemic began and we knew little about the virus itself or its epidemiologic behavior, it was assumed that it would behave, in terms of spread among communities, like other respiratory viruses. Little has presented itself after intense study of this virus and its behavior to change this perception.

This is somewhat of an unusual virus in that for the vast majority of people infected by the virus, one experiences either no illness (asymptomatic) or very little sickness. Only a very small number of people are at risk of a potentially serious outcome from the infection—mainly those with underlying serious medical conditions in conjunction with advanced age and frailty, those with immune compromising conditions and nursing home patients near the end of their lives. There is growing evidence that the treatment protocol issued to treating doctors by the Center for Disease Control and Prevention (CDC), mainly intubation and use of a ventilator (respirator), may have contributed significantly to the high death rate in these select individuals.

By wearing a mask, the exhaled viruses will not be able to escape and will concentrate in the nasal passages, enter the olfactory nerves and travel into the brain.  Russell Blaylock, MD

As for the scientific support for the use of face mask, a recent careful examination of the literature, in which 17 of the best studies were analyzed, concluded that, “ None of the studies established a conclusive relationship between mask/respirator use and protection against influenza infection.”1   Keep in mind, no studies have been done to demonstrate that either a cloth mask or the N95 mask has any effect on transmission of the COVID-19 virus. Any recommendations, therefore, have to be based on studies of influenza virus transmission. And, as you have seen, there is no conclusive evidence of their efficiency in controlling flu virus transmission.

It is also instructive to know that until recently, the CDC did not recommend wearing a face mask or covering of any kind, unless a person was known to be infected, that is, until recently. Non-infected people need not wear a mask. When a person has TB we have them wear a mask, not the entire community of non-infected. The recommendations by the CDC and the WHO are not based on any studies of this virus and have never been used to contain any other virus pandemic or epidemic in history.

Now that we have established that there is no scientific evidence necessitating the wearing of a face mask for prevention, are there dangers to wearing a face mask, especially for long periods? Several studies have indeed found significant problems with wearing such a mask. This can vary from headaches, to increased airway resistance, carbon dioxide accumulation, to hypoxia, all the way to serious life-threatening complications.

There is a difference between the N95 respirator mask and the surgical mask (cloth or paper mask) in terms of side effects. The N95 mask, which filters out 95% of particles with a median diameter >0.3 µm2 , because it impairs respiratory exchange (breathing) to a greater degree than a soft mask, and is more often associated with headaches. In one such study, researchers surveyed 212 healthcare workers (47 males and 165 females) asking about presence of headaches with N95 mask use, duration of the headaches, type of headaches and if the person had preexisting headaches.2

They found that about a third of the workers developed headaches with use of the mask, most had preexisting headaches that were worsened by the mask wearing, and 60% required pain medications for relief. As to the cause of the headaches, while straps and pressure from the mask could be causative, the bulk of the evidence points toward hypoxia and/or hypercapnia as the cause. That is, a reduction in blood oxygenation (hypoxia) or an elevation in blood C02 (hypercapnia). It is known that the N95 mask, if worn for hours, can reduce blood oxygenation as much as 20%, which can lead to a loss of consciousness, as happened to the hapless fellow driving around alone in his car wearing an N95 mask, causing him to pass out, and to crash his car and sustain injuries. I am sure that we have several cases of elderly individuals or any person with poor lung function passing out, hitting their head. This, of course, can lead to death.

A more recent study involving 159 healthcare workers aged 21 to 35 years of age found that 81% developed headaches from wearing a face mask.3   Some had pre-existing headaches that were precipitated by the masks. All felt like the headaches affected their work performance.

Unfortunately, no one is telling the frail elderly and those with lung diseases, such as COPD, emphysema or pulmonary fibrosis, of these dangers when wearing a facial mask of any kind—which can cause a severe worsening of lung function. This also includes lung cancer patients and people having had lung surgery, especially with partial resection or even the removal of a whole lung.

While most agree that the N95 mask can cause significant hypoxia and hypercapnia, another study of surgical masks found significant reductions in blood oxygen as well. In this study, researchers examined the blood oxygen levels in 53 surgeons using an oximeter. They measured blood oxygenation before surgery as well as at the end of surgeries.4 The researchers found that the mask reduced the blood oxygen levels (pa02) significantly. The longer the duration of wearing the mask, the greater the fall in blood oxygen levels.

The importance of these findings is that a drop in oxygen levels (hypoxia) is associated with an impairment in immunity. Studies have shown that hypoxia can inhibit the type of main immune cells used to fight viral infections called the CD4+ T-lymphocyte. This occurs because the hypoxia increases the level of a compound called hypoxia inducible factor-1 (HIF-1), which inhibits T-lymphocytes and stimulates a powerful immune inhibitor cell called the Tregs. . This sets the stage for contracting any infection, including COVID-19 and making the consequences of that infection much graver. In essence, your mask may very well put you at an increased risk of infections and if so, having a much worse outcome.5,6,7

People with cancer, especially if the cancer has spread, will be at a further risk from prolonged hypoxia as the cancer grows best in a microenvironment that is low in oxygen. Low oxygen also promotes inflammation which can promote the growth, invasion and spread of cancers.8,9  Repeated episodes of hypoxia has been proposed as a significant factor in atherosclerosis and hence increases all cardiovascular (heart attacks) and cerebrovascular (strokes) diseases.10

There is another danger to wearing these masks on a daily basis, especially if worn for several hours. When a person is infected with a respiratory virus, they will expel some of the virus with each breath. If they are wearing a mask, especially an N95 mask or other tightly fitting mask, they will be constantly rebreathing the viruses, raising the concentration of the virus in the lungs and the nasal passages. We know that people who have the worst reactions to the coronavirus have the highest concentrations of the virus early on. And this leads to the deadly cytokine storm in a selected number.

It gets even more frightening. Newer evidence suggests that in some cases the virus can enter the brain.11,12 In most instances it enters the brain by way of the olfactory nerves (smell nerves), which connect directly with the area of the brain dealing with recent memory and memory consolidation. By wearing a mask, the exhaled viruses will not be able to escape and will concentrate in the nasal passages, enter the olfactory nerves and travel into the brain.13

It is evident from this review that there is insufficient evidence that wearing a mask of any kind can have a significant impact in preventing the spread of this virus. The fact that this virus is a relatively benign infection for the vast majority of the population and that most of the at-risk group also survive, from an infectious disease and epidemiological standpoint, by letting the virus spread through the healthier population we will reach a herd immunity level rather quickly that will end this pandemic quickly and prevent a return next winter. During this time, we need to protect the at-risk population by avoiding close contact, boosting their immunity with compounds that boost cellular immunity and in general, care for them.

One should not attack and insult those who have chosen not to wear a mask, as these studies suggest that is the wise choice to make.

ref: https://www.technocracy.news/blaylock-face-masks-pose-serious-risks-to-the-healthy/

 

Comments are closed.